Anna Popova, the head of Russian public health watchdog Rospotrebnadzor, hopes that Phase 3 of trial of EpiVacCorona, Russia’s second registered vaccine against COVID-19, will begin soon.
“I hope the third phase will begin in a week,” she said in an interview with the Rossiya 1 broadcaster.
Continue reading https://sptnkne.ws/Epj8